Open access

Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)

Irene J Higginson, Andrew Wilcock, Miriam J Johnson, Sabrina Bajwah, Natasha Lovell, Deokhee Yi, Simon P Hart, Vincent Crosby, Heather Poad, David Currow, Emma Best, Sarah Brown, on behalf of BETTER-B Feasibility Trial Group, Rohit Lal, Charles Reilly, Matthew Maddocks, Surinder Birring, Anna Gerratt, Frank McCaughan, Rachael Barton, Irem Patel, West Wai Lam, Stuart Chandler, Deborah Tonkin, Julia Brown, Trevor Sheldon, Cathann Manderson, Sarah Farnan, Paramjote Kaler, Caty Pannell, Evelyne Burssens, Kayleigh Brindle, Caroline Wright, Anna Johnston, Maria Teixera, Hannah Buckley, Victoria Hiley, Heather Cook, Helen Howard, Jackie Pullen, Helen Critchley, Hinna Mir, Charlotte Bolton, William Chang, Gisli Jenkins

10.1136/thoraxjnl-2019-213879

January 8, 2020